252 related articles for article (PubMed ID: 2536127)
1. Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin.
Fayed YM; Tsibris JC; Langenberg PW; Robertson AL
Lab Invest; 1989 Jan; 60(1):30-7. PubMed ID: 2536127
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells.
Wang J; Ohara N; Takekida S; Xu Q; Maruo T
Hum Reprod; 2005 Jun; 20(6):1456-65. PubMed ID: 15760954
[TBL] [Abstract][Full Text] [Related]
3. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
[TBL] [Abstract][Full Text] [Related]
4. Binding of epidermal growth factor and insulin-like growth factor I in human myometrium and leiomyomata.
Tommola P; Pekonen F; Rutanen EM
Obstet Gynecol; 1989 Oct; 74(4):658-62. PubMed ID: 2797644
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.
Ohara N; Morikawa A; Chen W; Wang J; DeManno DA; Chwalisz K; Maruo T
Reprod Sci; 2007 Dec; 14(8 Suppl):20-7. PubMed ID: 18089606
[TBL] [Abstract][Full Text] [Related]
6. Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro.
Rossi MJ; Chegini N; Masterson BJ
Endocrinology; 1992 Mar; 130(3):1716-27. PubMed ID: 1311246
[TBL] [Abstract][Full Text] [Related]
7. Growth regulation in primary culture of rabbit arterial smooth muscle cells by platelet-derived growth factor, insulin-like growth factor-I, and epidermal growth factor.
Yamamoto M; Yamamoto K
Exp Cell Res; 1994 May; 212(1):62-8. PubMed ID: 8174643
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth.
Wolańska M; Bańkowski E
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):238-44. PubMed ID: 16564125
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.
Mioh H; Chen JK
J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412
[TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha inhibits the DNA synthesis induced by PDGF and EGF in cultured meningioma cells.
Zhang ZJ; Muhr C; Wang JL
Anticancer Res; 1996; 16(2):717-23. PubMed ID: 8687119
[TBL] [Abstract][Full Text] [Related]
11. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
Huang JS; Nishimura J; Huang SS; Deuel TF
J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
13. Mitogenic action of tumor necrosis factor in human fibroblasts: interaction with epidermal growth factor and platelet-derived growth factor.
Palombella VJ; Mendelsohn J; Vilcek J
J Cell Physiol; 1988 Apr; 135(1):23-31. PubMed ID: 3259236
[TBL] [Abstract][Full Text] [Related]
14. Presence of epidermal growth factor receptors and influence of epidermal growth factor on proliferation and aging in cultured smooth muscle cells.
Bhargava G; Rifas L; Makman MH
J Cell Physiol; 1979 Aug; 100(2):365-74. PubMed ID: 315948
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
16. Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells.
Cohick WS; Gockerman A; Clemmons DR
J Cell Physiol; 1995 Jul; 164(1):187-96. PubMed ID: 7540619
[TBL] [Abstract][Full Text] [Related]
17. Altered growth factor sensitivity in EL2 rat fibroblasts: influence of this biological characteristic on cell growth.
Di Francesco P; Testa EP; Testa U; Liboi E
Eur J Cell Biol; 1989 Jun; 49(1):196-201. PubMed ID: 2788084
[TBL] [Abstract][Full Text] [Related]
18. Different effects of epidermal growth factor on smooth muscle cells derived from human myometrium and from leiomyoma.
Ren Y; Yin H; Tian R; Cui L; Zhu Y; Lin W; Tang XD; Gui Y; Zheng XL
Fertil Steril; 2011 Oct; 96(4):1015-20. PubMed ID: 21821245
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy-stimulated growth of vascular smooth muscle cells: importance of protein kinase C-dependent synergy between estrogen and platelet-derived growth factor.
Keyes LE; Moore LG; Walchak SJ; Dempsey EC
J Cell Physiol; 1996 Jan; 166(1):22-32. PubMed ID: 8557771
[TBL] [Abstract][Full Text] [Related]
20. Modulation of platelet-derived growth factor receptor function in BP3T3, a chemically transformed BALB/c-3T3 cell line.
Grundy P; Bishayee S; Disa S; Scher CD
Cancer Res; 1989 Jul; 49(13):3581-6. PubMed ID: 2543499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
